欢迎访问行业研究报告数据库

行业分类

当前位置:首页 > 报告详细信息

找到报告 1 篇 当前为第 1 页 共 1

新兴医药市场报告(2016-2020年)

Pharmerging Markets 2016-2020

加工时间:2015-12-24 信息来源:EMIS 索取原文[104 页]
关键词:全球制药行业;市场营销模式;销售药品;医疗卫生;基础设施建设
摘 要:The global pharmaceutical industry is witnessing a paradigm shift in the marketing and sale of pharmaceutical products from developed regions to developing regions. These
目 录:

PART 01: Executive summary

Highlights

PART 02: Scope of the report

Market overview

PART 03: Market research methodology

Research methodology

Economic indicators

PART 04: Introduction

Key market highlights

PART 05: Global pharmaceuticals market

Market size and forecast

PART 06: Pharmerging markets

PART 07: Market landscape

Market size and forecast

Five forces analysis

PART 08: Market segmentation based on geography

PART 09: Market overview of Tier I countries

China

PART 10: Market overview of Tier II countries

Brazil

Russia

India

PART 11: Market overview of Tier III countries

Market size and forecast

PART 12: Market drivers

Social and private health insurance

Increase in healthcare spending

High incidence of diseases

Impact of patent cliff on mature markets

PART 13: Impact of drivers

PART 14: Market challenges

Affordability and access

High competition

Partial regulatory policies

Price pressure

PART 15: Impact of drivers and challenges

PART 16: Market trends

Strategic alliances

Increase in generic sales

Mergers and acquisitions

Early drug launches in pharmerging markets

PART 17: Vendor landscape

Competitive scenario

AstraZeneca

GlaxoSmithKline

Merck

Novartis

Pfizer

Sanofi

Other prominent vendors

PART 18: Appendix

List of abbreviations

PART 19: Explore Technavio
© 2016 武汉世讯达文化传播有限责任公司 版权所有 技术支持:武汉中网维优
客服中心

QQ咨询


点击这里给我发消息 客服员


电话咨询


027-87841330


微信公众号




展开客服